Pomerantz LLP is investigating Enova International for potential securities fraud after the company withdrew its application to acquire Grasshopper Bancorp, which would have made it a bank holding company. Enova cited unclear regulatory standards and political pressures as reasons for the withdrawal. Following this announcement, Enova's stock price fell sharply by 23.43%. The investigation aims to determine if Enova and its executives engaged in unlawful business practices affecting investors.
Enova International, Inc. is the subject of an investor investigation. For readers following Financials, here is Pluang's market snapshot as of Oct 21, 2026 02:31 WIB: Out of 142 priced Financials-sector US stocks, 124 rose and 18 fell. Notable movers include FNB at USD 17.57 (+3.60%), XP at USD 31.30 (+3.44%), and BBD at USD 4.08 (+3.43%) with BBD showing 0% Sell / 100% Buy order activity and a typical hold time of 6 days on Pluang.
Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...
Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...
Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...
Piper Sandler upgraded Myriad Genetics from Underweight to Neutral and set a $5.00 price target after the company agreed to sell its prenatal health testing business to Labcorp for $210 million in cash. This sale includes several prenatal tests and i...
Brunello Cucinelli, an Italian luxury fashion company, raised its 2026 outlook following stronger-than-expected third-quarter sales. Citigroup maintains a Buy rating on the stock, which trades around $9.43 with a market cap of approximately $6.41 bil...
